Urban Supreme System

Su Zhe's final decision was not surprising to Li Changhua and Liu Xiong.

Li Changhua and the others had already thought about it beforehand. It was not surprising that Su Zhe would decide like this.

Now that Su Zhe has decided, the matter has been settled. The three medicines of Thaw Lingtai will not be sold abroad until the production is increased before making a decision.

In fact, Su Zhe and the others are not too worried that they will lose this opportunity to attack the world.

Because other pharmaceutical companies do not have therapeutic potions, it is basically impossible to imitate Thalysin and other drugs.

Similarly, it is currently impossible to develop a drug that has the same effect as Thaws without a healing potion.

Otherwise, so many people around the world are troubled by ALS. If it could be developed so easily, it would be impossible for there to be no other specific medicine except Thalysin that can cure ALS.

Therefore, the advantages that Changhua Pharmaceutical Factory has cannot be broken in the future.

What's more, Changhua Pharmaceutical Factory not only has three types of medicines, including Thaysalin, Sleeping Spirit, and Xingshen Pills. Soon, Changhua Pharmaceutical Factory will also launch blue elixir on the market, which is unmatched by other special medicines.

Moreover, Changhua Pharmaceutical Factory will continue to launch drugs one after another in the future. With this advantage, there is no problem in building Changhua Pharmaceutical Factory into a world-class pharmaceutical company.

So even if Changhua Pharmaceutical Factory loses this opportunity now, Su Zhe and the others are not worried.

at last. After arranging these things. Su Zhe and Li Changhua. We started discussing the blue elixir again.

Now the blue elixir has reached the final part of clinical trials. So many tests have been done. It is basically impossible to fail now. We are just waiting for the final results to come out. Then the production approval document for the blue elixir from the Food and Drug Administration It will come down.

Now everything is ready, even all the raw materials and production lines are ready for the blue elixir, just waiting for the approval. Then the blue elixir can be mass-produced and launched on the market.

Therefore, a decision must be made now about putting the blue elixir on the shelves.

The most important thing is the wholesale price and final retail price of the blue elixir.

before this,

Li Changhua has asked professionals to calculate the blue elixir, raw material costs and labor costs, as well as various related tax rates that need to be paid.

Li Changhua showed this information to Su Zhe. In fact, the cost of producing the blue elixir was nothing. The most important thing was that the cost of the treatment potion was relatively high.

And there is every blue elixir sold. Changhua Pharmaceutical Factory also needs to pay an additional RMB 1 production authorization fee to Su Zhe.

Because of the formula of this blue elixir. It was provided to Changhua Pharmaceutical Factory by Su Zhe, so if Changhua Pharmaceutical Factory produces blue elixir, it will need to pay a licensing fee of 1 yuan, which has been negotiated between Su Zhe and Li Changhua.

1 ml of healing potion can produce 10 pieces of blue elixir. The cost is 5 yuan, plus a licensing fee of 1 yuan, so the two items add up to 6 yuan.

The cost of other raw materials is relatively low. If relevant taxes are included, the production cost of blue elixir is not low.

The information Li Changhua provided to Su Zhe included the recommended price from professionals. Su Zhe combined it with the actual situation and finally said: "The wholesale price of blue elixir is set at 8 yuan. Is there any problem?"

If the wholesale price of the blue elixir is 8 yuan, then the profit is about 0.8 yuan, which is almost the same as the profit of Membrane and Xingshen tablets, so the profit of the blue elixir is not high.

However, considering the future market of blue elixir, this will be a huge profit.

Both Li Changhua and Liu Xiong felt that there was no problem with the pricing, and they had no objections.

After negotiating the wholesale price of the blue elixir, the next step is to negotiate the final retail price of the drug store.

"If the wholesale price is 8 yuan, then the retail price in the drugstore is 9 yuan." Liu Xiong thought for a while and said.

"It's been decided for now." Finally, Su Zhe said.

Liu Xiong has already discussed the issue of retail price with the senior management of Liu Group and has come to a result, so Liu Xiong can now tell the result.

Because Changhua Pharmaceutical Factory and Liu Group had already reached an agreement when they signed the exclusive agency rights for Blue Spirit Medicine. The final retail price must be agreed upon by both parties and cannot be decided by one party.

Otherwise, Changhua Pharmaceutical Factory will have the right to take back the exclusive agency rights of Blue Elixir.

In fact, it is not only the blue elixir, but also other medicines such as Thawling Ling. The retail price is agreed upon by both parties.

In this way, Su Zhecai can ensure that the retail price of the medicines provided to the market will not be too expensive and some people will not be unable to afford the medicines.

This was Su Zhe's consideration. Otherwise, it would be meaningless if he set the wholesale price of Thaeling and other drugs at such a low price.

Only in this way can Su Zhe control the retail price of drugs and try to control the retail price within an acceptable range.

Although Liu Xiong is the chairman of the Liu Group, the Liu Group does not belong to Liu Xiong after all, and he cannot make full decisions.

At that time, the retail prices of Thalysin and other drugs were set so low that some senior executives of the Liu Group were quite dissatisfied. However, since the agreement had been signed, they were not allowed to make the final decision.

Moreover, Changhua Pharmaceutical Factory can withdraw its exclusive agency rights at any time, which controls the lifeblood of Liu Group and leaves some opponents helpless.

Because the state attaches great importance to Changhua Pharmaceutical Factory, policies have also provided convenience. Taxes on drugs such as Thawsing Ling are relatively low. This is also included in the blue elixir that is about to be launched.

It is also because of this that Su Zhe can control the wholesale price and retail price within a minimum range.

If it were not for the convenience provided by the policy, Changhua Pharmaceutical Factory and Liu Group would not have a single profit after paying taxes, and it would be impossible to set the price at such a low level.

Of course, this policy also has limitations. If the price is too high, even if it can be approved by the Food and Drug Administration, Changhua Pharmaceutical Factory and Liu Group will no longer be able to enjoy the preferential policies and will have to pay normal taxes.

However, the current pricing of the three drugs launched by Changhua Pharmaceutical Factory, as well as the blue elixir that will be put on the shelves in the future, are within the scope of policy restrictions, and you can enjoy the discounts.

Therefore, Su Zhe set the wholesale and retail prices at such low prices, so Changhua Pharmaceutical Factory and Liu Group can still make profits. (To be continued...) ()